Jones Jeffrey Alan Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$130,660.73

Insider Activity of Jones Jeffrey Alan

According to the SEC Form 4 filings, Jones Jeffrey Alan, being in a position of

  1. Chief Medical Officer at Cullinan Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 14196 shares for $178,948,
    over all time since 2023-03-20, has bought 0 shares, and sold 27532 shares for $309,609.

Biography of Jones Jeffrey Alan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$178,9483100

Comparison of Insiders on Amount of Buys and Sells

2026-02-24SaleCullinan Therapeutics, Inc.
CGEM
Chief Medical Officer
4,582
0.0079%
$14.47$66,302+8.34%
2026-02-20SaleCullinan Therapeutics, Inc.
CGEM
Chief Medical Officer
4,982
0.0084%
$13.62$67,855+13.19%
2025-12-18SaleCullinan Therapeutics, Inc.
CGEM
Chief Medical Officer
4,632
0.0076%
$9.67$44,791+49.5%
2025-02-25SaleCullinan Oncology, Inc.
CGEM
Chief Medical Officer
4,895
0.0079%
$8.53$41,754-4.91%
2024-12-18SaleCullinan Oncology, Inc.
CGEM
Chief Medical Officer
4,632
0.0085%
$11.41$52,851-24.47%
2023-12-21SaleCullinan Oncology, Inc.
CGEM
Chief Medical Officer
1,860
0.0039%
$8.50$15,810+79.11%
2023-12-18SaleCullinan Oncology, Inc.
CGEM
Chief Medical Officer
386
0.0008%
$8.22$3,173+85.76%
2023-06-20SaleCullinan Oncology, Inc.
CGEM
Chief Medical Officer
387
0.0009%
$12.94$5,008-16.6%
2023-05-18SaleCullinan Oncology, Inc.
CGEM
Chief Medical Officer
394
0.001%
$8.76$3,451+20.45%
2023-04-18SaleCullinan Oncology, Inc.
CGEM
Chief Medical Officer
392
0.001%
$10.71$4,198+1.31%
2023-03-20SaleCullinan Oncology, Inc.
CGEM
Chief Medical Officer
390
0.001%
$11.32$4,415-5.51%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.